The main obstacle to using “reprogrammed” human stem cells – the danger that they might turn cancerous – have been solved, claims a US company. PrimeGen, based in Irvine, California, says that its scientists have converted specialised adult human cells back to a seemingly embryonic state – using methods that are much less likely to trigger cancer than those deployed previously.
